The Role of Secondary Surgery in Recurrent Ovarian Cancer
Joint Authors
Raspagliesi, F.
Di Rocco, R.
Fontanelli, R.
Mancini, M.
Lo Russo, D.
Source
International Journal of Surgical Oncology
Issue
Vol. 2012, Issue 2012 (31 Dec. 2012), pp.1-6, 6 p.
Publisher
Hindawi Publishing Corporation
Publication Date
2012-08-05
Country of Publication
Egypt
No. of Pages
6
Main Subjects
Abstract EN
Despite optimal treatment (complete cytoreduction and adjuvant chemotherapy), 5-year survival for advanced ovarian cancer is approximately 30% and most patients succumb to their disease.
Cytoreductive surgery is accepted as a major treatment of primary ovarian cancer but its role in recurrent disease is controversial and remains a field of discussion mainly owing to missing data from prospective randomized trials.
A critical review of literature evidence on secondary surgery in recurrent ovarian cancer will be described.
American Psychological Association (APA)
Lo Russo, D.& Mancini, M.& Di Rocco, R.& Fontanelli, R.& Raspagliesi, F.. 2012. The Role of Secondary Surgery in Recurrent Ovarian Cancer. International Journal of Surgical Oncology،Vol. 2012, no. 2012, pp.1-6.
https://search.emarefa.net/detail/BIM-485190
Modern Language Association (MLA)
Lo Russo, D.…[et al.]. The Role of Secondary Surgery in Recurrent Ovarian Cancer. International Journal of Surgical Oncology No. 2012 (2012), pp.1-6.
https://search.emarefa.net/detail/BIM-485190
American Medical Association (AMA)
Lo Russo, D.& Mancini, M.& Di Rocco, R.& Fontanelli, R.& Raspagliesi, F.. The Role of Secondary Surgery in Recurrent Ovarian Cancer. International Journal of Surgical Oncology. 2012. Vol. 2012, no. 2012, pp.1-6.
https://search.emarefa.net/detail/BIM-485190
Data Type
Journal Articles
Language
English
Notes
Includes bibliographical references
Record ID
BIM-485190
